Aquestive Therapeutics, Inc. Common Stock

AQSTNASDAQ • USD
3.76 USD
↘ 0.16 (3.96%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $3.76. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Strong Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (111.9%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.88
High?$4.38
Low?$3.72
Prev. Close?$3.91
Volume?1.2M
Avg. Volume?2.4M
VWAP?$3.79
Rel. Volume?0.49x
Bid / Ask
Bid?$3.75 × 1.0K
Ask?$3.76 × 1.3K
Spread?$0.01
Midpoint?$3.76
Valuation & Ratios
Market Cap?491.4M
Shares Out?125.7M
Float?107.7M
Float %?85.8%
P/E Ratio?N/A
P/B Ratio?-6.94
EPS?-$0.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
491.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-07-25
Address
184 LIBERTY CORNER ROAD
WARREN, NJ
Phone: 908-941-1900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
14
Short Sent.?
5
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.53Distress
Confidence?76%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?27.23%Squeeze Risk
Short Interest?29.3M
Days to Cover?13.2
Free Float107.7M
Avg Daily Volume2.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?6.12Strong
Quick Ratio?5.69Strong
Cash Ratio?5.22Strong
Debt/Equity?-0.72Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-6.94CHEAP▾
P/S?
Peers
100
S&P
8
10.06HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.0CHEAP▾
EV/Sales?
Peers
100
S&P
13
9.25HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
111.9%STRONG▾
ROA?
S&P
3
-66.4%WEAK▾
Cash Flow & Enterprise
FCF?$-40695000
Enterprise Value?$451.9M
Fundamentals ratios updated end of day